Loading...

UnitedHealth Group Incorporated

UNHNYSE
Healthcare
Medical - Healthcare Plans
$271.49
$-0.32(-0.12%)

UnitedHealth Group Incorporated (UNH) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for UnitedHealth Group Incorporated (UNH), covering cash flow, earnings, and balance sheets.

Revenue Growth
7.71%
7.71%
Operating Income Growth
-0.22%
0.22%
Net Income Growth
-35.64%
35.64%
Operating Cash Flow Growth
-16.73%
16.73%
Operating Margin
7.30%
7.30%
Gross Margin
20.53%
20.53%
Net Profit Margin
5.06%
5.06%
ROE
22.26%
22.26%
ROIC
15.55%
15.55%

UnitedHealth Group Incorporated (UNH) Income Statement & Financial Overview

Review UnitedHealth Group Incorporated UNH income statement with detailed quarterly and annual figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$109.58B$100.81B$99.18B$97.86B
Cost of Revenue$85.80B$79.50B$77.79B$76.80B
Gross Profit$23.77B$21.31B$21.39B$21.06B
Gross Profit Ratio$0.22$0.21$0.22$0.22
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$0.00$0.00$0.00$0.00
Operating Expenses$14.65B$13.54B$12.68B$13.19B
Total Costs & Expenses$100.46B$93.03B$90.47B$89.98B
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$998.00M$1.003B$1.07B$985.00M
Depreciation & Amortization$1.06B$1.04B$1.04B$1.02B
EBITDA$10.16B$8.84B$9.73B$7.67B
EBITDA Ratio$0.09$0.09$0.10$0.08
Operating Income$9.12B$7.77B$8.71B$7.88B
Operating Income Ratio$0.08$0.08$0.09$0.08
Other Income/Expenses (Net)-$1.01B-$982.00M-$1.09B-$2.21B
Income Before Tax$8.11B$6.79B$7.61B$5.67B
Income Before Tax Ratio$0.07$0.07$0.08$0.06
Income Tax Expense$1.63B$1.007B$1.36B$1.24B
Net Income$6.29B$5.54B$6.05B$4.22B
Net Income Ratio$0.06$0.05$0.06$0.04
EPS$6.91$5.98$6.56$4.58
Diluted EPS$6.85$5.98$6.51$4.54
Weighted Avg Shares Outstanding$918.00M$927.00M$923.00M$921.00M
Weighted Avg Shares Outstanding (Diluted)$918.00M$927.00M$930.00M$928.00M

Financial performance has remained strong, with revenue growing from $97.86B in Q2 2024 to $109.58B in Q1 2025. Gross profit continued to perform well, with margins at 22% in the latest quarter. Operating income reached $9.12B in Q1 2025, holding a steady 8% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $10.16B. Net income rose to $6.29B, keeping EPS at $6.91. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;